In both regimens , @-agonist use increased before hospital attendance , with a median ( range ) maximum daily number of actuations of @ ( @ to @ ) budesonide/formoterol in SMART and @ ( @ to @ ) salbutamol in Standard with @ ( @ to @ ) budesonide/formoterol actuations on the day of maximal salbutamol use .